Whole Slide Imaging Trade-Offs in Hematopathology Diagnostics

Is Whole Slide Imaging ready to replace the microscope? Compare the benefits of Full-Field imaging vs. traditional WSI for bone marrow and peripheral blood smears.

The Future of Digital Hematopathology: Overcoming WSI Limitations

Over the past three decades, advances in technology have moved diagnostic medicine into an era of digital transformation. The development of robust whole-slide imaging (WSI), together with improvements in image analysis and digital storage, has enabled digital pathology to be integrated into clinical workflows.¹ Hematology and hematopathology — historically early adopters of digital imaging — are seeing changes in workflow efficiency, collaboration, and diagnostic practice.¹ At the same time, artificial intelligence (AI) is expanding image analysis capabilities, supporting classification, detection, and quantitative disease assessment.² However, the transition from glass slides to pixels involves complex trade-offs between resolution, data volume, and diagnostic speed.

How is Whole Slide Imaging Used in Hematopathology Diagnostics?

The introduction of robust whole-slide imaging (WSI) technologies has enabled digital pathology to be incorporated into routine clinical workflows, marking a significant shift in how microscopic images are handled and interpreted. In hematopathology, WSI is applied across various specimen types:¹

• Peripheral blood smears
• Bone marrow aspirate smears
• Bone marrow cores
• Lymph node specimens

By digitizing these samples, laboratories can optimize workflows, enable remote hematopathology consultations, and enhance inter-institutional collaboration as well as research and teaching.¹

What is the Role of AI in Hematologic Image Analysis?

Artificial Intelligence (AI) and Convolutional Neural Networks (CNNs) are expanding the utility of WSI. These tools support:²

• Leukocyte differential counting
• Malaria species identification
• Detection of acute leukemia and lymphoproliferative diseases
• Automated quantitative assessment to reduce inter-operator variability

Commercially available systems also automate aspirate differential counts and provide digital analysis of smear preparations.¹

The Critical Trade-Offs in Whole Slide Imaging: Resolution vs. Field of View

One of the primary challenges in digital hematopathology is balancing image detail with scanning efficiency.

1. Z-Stacking and Three-Dimensional Structures

Unlike paraffin-embedded bone marrow cores, which can often be digitized in a single focal plane, peripheral blood smears require multiple focus planes to visualize 3D cell structures.

The Solution: Z-stacking (capturing images at multiple depths).¹
The Trade-off: This substantially increases both scanning time and final file size.¹

2. Rare Cell Detection and Magnification

To avoid false negatives in rare event detection, hematopathologists must analyze large slide areas, where image acquisition speed becomes critical.²

Rare event detection requires imaging extensive areas of a smear, making acquisition speed and efficient review processes particularly important.² Standard scanners typically provide rapid scanning at x20 or x40 magnification. The limitation: these magnifications are often lower than the high-power oil immersion fields (x100) traditionally required for detailed morphological assessment.

3. Data Volume and Infrastructure Demands in Whole Slide Imaging

High-resolution scanning and multi-plane imaging create significant technical demands related to storage and digital infrastructure. A single digital slide can reach several gigabytes in size, necessitating:¹

• Robust Digital Infrastructure: High-speed networks for image transfer.
• Optimized Storage: Cost-effective, long-term data management solutions to make clinical implementation feasible.

Clinical Implications of Whole Slide Imaging Review Practices: Why Go Digital?

Transitioning to a digital workflow offers measurable improvements in turnaround times and operational costs:¹

• Elimination of Physical Transport: Digitization at the site of preparation removes the need for couriers and reduces the risk of slide breakage.¹
• Remote Consultation: Real-time access to slides allows for concurrent review and faster participation in treatment planning discussions (tumor boards).¹
• Standardization: AI-assisted analysis reduces the subjectivity of manual morphology, leading to more consistent patient results.^2,3

Where does Whole Slide Imaging fit within Modern Hematopathology?

Advances in technology over the past three decades have brought diagnostic medicine into an era of digital innovation, with hematology historically leading aspects of digital adoption. Despite this experience, the diversity of specimen types in hematopathology has created obstacles to full digital transformation.¹

Nevertheless, the integration of WSI, optimized storage systems, and AI-driven image analysis is reshaping laboratory hematology and hematopathology services, creating opportunities for data sharing, research, collaboration, and expanded remote service provision.^1,3

The Scopio Labs Advantage: Full-Field Imaging*

Traditional WSI often forces a choice between speed and detail. Scopio Labs’ Full-Field imaging platform eliminates this trade-off.

• 100× Magnification: Captures the entire bone marrow aspirate slide at ultra-high resolution without losing the field of view.⁴
• Seamless Navigation: Users can zoom and navigate across the entire smear as if using a manual microscope, but with the benefits of digital AI-based pre-classification of nucleated cells and decision-support tools to assist with differential counts and morphology review, helping to improve workflow efficiency and consistency.⁵
• Secure Remote Access*: The fully digital workflow facilitates instant global collaboration and flexible reporting across multiple laboratory sites.

Disclaimers:

*Scopio Labs’ Full-Field Peripheral Blood Smear application is CE marked and FDA-cleared, and it’s commercially available across the U.S., UK and Europe and other territories.
*Scopio Labs’ Full-Field Bone Marrow Aspirate Application is CE-marked and cleared for sale in additional regions. Not commercially available in the US for in vitro diagnostic procedures.
*Remote capabilities are available through the secure hospital network.

References:

1. Shean RC, Rets AV. Digital Pathology in Hematopathology: From Vision to Deployment. Int J Lab Hematol. 2025. doi: 10.1111/ijlh.14533
2. Lee SY, Chen CM, Lim EY, Shen L, Sathe A, Singh A, et al. Image analysis using machine learning for automated detection of hemoglobin H inclusions in blood smears – A method for morphologic detection of rare cells. J Pathol Inform 2021;12:18. doi: 10.4103/jpi.jpi_110_20
3. Omoush SA, Alzyoud JAM, El-Omari NKT, Alzyoud AJA, et al. The role of whole slide imaging in AI-based digital pathology: current challenges and future directions. J Mol Pathol. 2026;7(2):2. doi: 10.3390/jmp7010002
4. Katz B-Z, et al. Evaluation of Scopio Labs X100 Full Field PBS: The first high-resolution full field viewing of peripheral blood specimens combined with artificial intelligence-based morphological analysis. Int J Lab Hematol. 2021;00:19. https://doi.org/10.1111/ijlh.13681
5. Bruker G. Digital Pathology: Benefits, Future Trends and Beyond. Available at: www.scopiolabs.com